Search results
Results From The WOW.Com Content Network
The first case of the COVID-19 pandemic in the Indian capital of Delhi was reported on 2 March 2020. Delhi has the seventh-highest number of confirmed cases of COVID-19 in India. The total number of cases reported as of Apr 2022, is 1,867,572 consisting of 26,158 deaths and 1,840,342 who have recovered. [1]
The 2022–2023 mpox outbreak in India is a part of the ongoing outbreak of human mpox caused by the West African clade of the monkeypox virus.The outbreak was first reported in India on 14 July 2022 when Kerala's State Health Minister Veena George announced a suspected imported case which was confirmed hours later by the NIV.
In addition, a person is sometimes infected with both hepatitis B virus (HBV) and HIV, and this population (about 2.7 million) accounts for about 1% of the total HBV infections. [ 23 ] Hepatitis C : According to the World Health Organization, there are approximately 58 million people with chronic hepatitis C, with about 1.5 million new ...
By late April, India led the world in new and active cases. On 30 April 2021, it became the first country to report over 400,000 new cases in a 24-hour period. [ 15 ] [ 6 ] Experts stated that the virus may reach an endemic stage in India rather than completely disappear; [ 16 ] in late August 2021, Soumya Swaminathan said India may be in some ...
Mosquitoes infected with West Nile virus have been detected in another Hamilton County community. A group of mosquitoes recently trapped on Foley Road in Delhi Township tested positive for West ...
Viral haemorrhagic fever, including Lassa fever, Marburg virus, and Ebola virus: Viral hemorrhagic fever: Viral hemorrhagic fever, including Arenavirus (new world), Crimean-Congo hemorrhagic fever, Dengue hemorraghic fever, Ebola virus, Lassa virus, Marburg virus: Flavivirus infection (unspecified), including Zika virus: Zika virus infection
In May 2022, the UK Human Animal Infections and Risk Surveillance (HAIRS) group [63] warned that the virus could reach wildlife and become endemic as a result. [ 64 ] [ 65 ] There was a concern that if the ongoing outbreak is prolonged, it "could establish new ecological niches in wild animals" in regions outside of Africa.
In March 2022, Ocugen registered a Phase 2/3 trial for 400 people in the US to compare the immune responses to those in people in the Indian phase 3 trial, as well as safety and tolerability. [44] The trial also aims to assess the vaccine as a booster after other Covid vaccines used in the US.